Nuvation Bio Company Insiders

Nuvation Bio Management Team Effectiveness

The company has return on total asset (ROA) of (0.1802) % which means that it has lost $0.1802 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0627) %, meaning that it created substantial loss on money invested by shareholders. Nuvation Bio's management efficiency ratios could be used to measure how well Nuvation Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of March 20, 2025, Return On Tangible Assets is expected to decline to -1.11. The current year's Return On Capital Employed is expected to grow to -1.17. At present, Nuvation Bio's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Assets is expected to grow to about 541.4 M, whereas Total Current Assets are forecasted to decline to about 459.3 M. As of March 20, 2025, Common Stock Shares Outstanding is expected to decline to about 221.2 M. The current year's Net Loss is expected to grow to about (89.1 M)

Nuvation Bio Workforce Comparison

Nuvation Bio Insider Trading

Nuvation Bio Notable Stakeholders

The success or failure of an entity such as Nuvation Bio often depends on how effective the management is. Nuvation Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nuvation management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nuvation management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Nuvation Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nuvation Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Nuvation Bio's management manipulating its earnings.

When running Nuvation Bio's price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.